bm 13505 has been researched along with sq 29548 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hunt, JA; Keen, M; MacDermot, J; Merritt, JE | 1 |
| Ishii, A; Kase, H; Miki, I | 1 |
| Allen, GT; Ogletree, ML | 1 |
| Le Breton, GC; Lim, CT; Vaidya, CM; Venton, DL | 1 |
| Lefer, AM; Smith, JB; Yanagisawa, A; Zipkin, R | 1 |
| Bertolino, F; Bessac, AM; Colpaert, FC; Delhon, A; Grelac, F; Lévy-Toledano, S; Maclouf, J; Maffre, M; Patoiseau, JF; Valentin, JP | 1 |
| Bertolino, F; Colpaert, FC; John, GW; Patoiseau, JF; Rieu, JP; Valentin, JP | 1 |
| Lane, K; Marshall, K; Senior, J | 1 |
| Gresele, P; Mezzasoma, AM; Venditti, G; Vezza, R | 1 |
9 other study(ies) available for bm 13505 and sq 29548
| Article | Year |
|---|---|
Characterization of the thromboxane receptor mediating prostacyclin release from cultured endothelial cells.
Topics: Bradykinin; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Cell Membrane; Cells, Cultured; Endothelium, Vascular; Epoprostenol; Fatty Acids, Unsaturated; Humans; Hydrazines; Phenylacetates; Phosphatidylinositols; Prostaglandin Endoperoxides, Synthetic; Radioligand Assay; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2 | 1992 |
Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.
Topics: Animals; Benzimidazoles; Benzoxepins; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Cells, Cultured; Fatty Acids, Unsaturated; Hydrazines; Male; Muscle, Smooth, Vascular; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Wistar; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Sulfonamides; Thromboxane A2 | 1992 |
Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Drug Antagonism; Fatty Acids, Unsaturated; Heptanoic Acids; Hydrazines; Indoles; Male; Muscle, Smooth, Vascular; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Receptors, Prostaglandin; Receptors, Thromboxane; Species Specificity; Sulfonamides; Thromboxane A2 | 1992 |
Thromboxane A2/prostaglandin H2 receptor antagonists.
Topics: Binding, Competitive; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Cell Membrane; Fatty Acids, Unsaturated; Humans; Hydrazines; In Vitro Techniques; Kinetics; Molecular Structure; Phenylacetates; Prostaglandins H; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Structure-Activity Relationship; Sulfonamides; Thromboxane A2 | 1990 |
Constriction of cat coronary arteries by synthetic thromboxane A2 and its antagonism.
Topics: Animals; Bicyclic Monoterpenes; Bridged Bicyclo Compounds, Heterocyclic; Cats; Coronary Vessels; Fatty Acids, Unsaturated; Hydrazines; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Sulfonamides; Thromboxane A2; Vasoconstriction | 1987 |
Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Platelets; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Hematocrit; Humans; Hydrazines; In Vitro Techniques; Male; Phenylacetates; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Sulfonamides; Thromboxane A2; Thromboxanes | 1995 |
Evidence for partial agonist properties of daltroban (BM 13,505) at TP receptors in the anaesthetized open-chest rat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Fatty Acids, Unsaturated; Hydrazines; Hypertension, Pulmonary; Male; Phenylacetates; Rats; Receptors, Thromboxane; Sulfonamides; Thromboxane A2 | 1997 |
Growth inhibitory effects of thromboxane antagonists on breast cancer cell lines: a preliminary study.
Topics: Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Division; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Female; Humans; Hydrazines; Phenylacetates; Prostaglandins, Synthetic; Sulfonamides; Thromboxanes; Tumor Cells, Cultured | 1997 |
Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aspirin; Biphenyl Compounds; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Calcium Signaling; Cells, Cultured; Enzyme Inhibitors; Fatty Acids, Unsaturated; Heptanoic Acids; Humans; Hydrazines; Imidazoles; Inositol Phosphates; Kidney; Methacrylates; Phenylacetates; Platelet Activating Factor; Platelet Activation; Prostaglandin H2; Prostaglandins H; Protein Isoforms; Receptors, Thromboxane; Recombinant Fusion Proteins; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 2002 |